In fact, there have been several clinical trials that have sought to treat IBD patients with recombinant GM-CSF (44), and while not efficacious in all patients, treatment with recombinant GM-CSF was able to successfully decrease colitis severity (13–16). The gene discussed is CSF2; the disease is colitis.